PUOTI MASSIMO

Capsoni, N., Bettina, M., Bellone, B., Bossi, I., Cantu, L., Rossmann, M., et al. (2026). Empirical piperacillin/tazobactam vs carbapenems to treat bloodstream infections due to ESBL enterobacterales: a propensity score-matched observational study conducted in an emergency department in Northern Italy. INFECTIOUS DISEASES, 58(5), 495-506 [10.1080/23744235.2025.2600010]. Dettaglio

Bana, N., Artelli, F., Lapadula, G., Bonfanti, P., Vitiello, P., Abeli, C., et al. (2026). Safety of cabotegravir + rilpivirine long-acting regimen among PLWH with previous HBV exposure: preliminary results of the SCRIBE study. In Abstracts from the 18th Italian Conference on AIDS and Antiviral Research (pp.92-94) [10.1136/sextrans-icar-2026.90]. Dettaglio

Vergori, A., Cervo, A., Roen, A., Gagliardini, R., Clemente, T., Mazzotta, V., et al. (2026). Risk of Developing Low-Level Viral Rebound Among People With HIV Receiving 2- or 3-Drug Regimens: A Case-Control Study Nested in the ICONA Cohort. OPEN FORUM INFECTIOUS DISEASES, 13(5) [10.1093/ofid/ofag250]. Dettaglio

Micheli, G., Mondi, A., Roen, A., Taramasso, L., Luchetti, I., Mazzotta, V., et al. (2026). Did the COVID-19 pandemic shift the landscape of late HIV diagnosis?. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 165(April 2026) [10.1016/j.ijid.2026.108437]. Dettaglio

D'Arminio Monforte, A., Lentini, N., Tavelli, A., Rusconi, S., Sozio, F., Guida, A., et al. (2026). Proportion of newly diagnosed persons with HIV with HIV-RNA greater than/equal to 500 000 copies/mL in 2018–2023 in Italy: data from the ICONA Foundation Cohort Study. CLINICAL MICROBIOLOGY AND INFECTION, 32(5), 866-869 [10.1016/j.cmi.2026.01.007]. Dettaglio